128 related articles for article (PubMed ID: 29970702)
1. Serum B7 homologous body 4 for the diagnosis of ovarian cancer in Chinese Han women: A meta-analysis.
Lan Z; Fu D; Xi M
J Cancer Res Ther; 2018 Jun; 14(Supplement):S433-S436. PubMed ID: 29970702
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the novel serum markers B7-H4, Spondin 2, and DcR3 for diagnosis and early detection of ovarian cancer.
Simon I; Liu Y; Krall KL; Urban N; Wolfert RL; Kim NW; McIntosh MW
Gynecol Oncol; 2007 Jul; 106(1):112-8. PubMed ID: 17490732
[TBL] [Abstract][Full Text] [Related]
3. Does B7-H4 expression correlate with clinicopathologic characteristics and survival in ovarian cancer?: A systematic review and PRISMA-compliant meta-analysis.
Ye Y; Wang JJ; Li SL; Wang SY; Jing FH
Medicine (Baltimore); 2018 Aug; 97(32):e11821. PubMed ID: 30095655
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic values of osteopontin combined with CA125 for ovarian cancer: a meta-analysis.
Lan Z; Fu D; Yu X; Xi M
Fam Cancer; 2016 Apr; 15(2):221-30. PubMed ID: 26458935
[TBL] [Abstract][Full Text] [Related]
5. A meta-analysis of serum cancer antigen 125 array for diagnosis of ovarian cancer in Chinese.
Liao XY; Huang GJ; Gao C; Wang GH
J Cancer Res Ther; 2014 Nov; 10 Suppl():C222-4. PubMed ID: 25450287
[TBL] [Abstract][Full Text] [Related]
6. Clinical Value of Combined Determination of Serum B7-H4 with Carcinoembryonic Antigen, Osteopontin, or Tissue Polypeptide-Specific Antigen for the Diagnosis of Colorectal Cancer.
Wang P; Li C; Zhang F; Ma X; Gai X
Dis Markers; 2018; 2018():4310790. PubMed ID: 30363700
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of HE4 in ovarian cancer: A meta-analysis.
Huang J; Chen J; Huang Q
Eur J Obstet Gynecol Reprod Biol; 2018 Dec; 231():35-42. PubMed ID: 30317143
[TBL] [Abstract][Full Text] [Related]
8. Combined detection of CA19-9 and B7-H4 in the diagnosis and prognosis of pancreatic cancer.
Xu X; Xiao Y; Hong B; Hao B; Qian Y
Cancer Biomark; 2019; 25(3):251-257. PubMed ID: 31282407
[TBL] [Abstract][Full Text] [Related]
9. Prognostic role of B7-H4 in patients with non-small cell lung cancer: A meta-analysis.
Tan Z; Shen W
Oncotarget; 2017 Apr; 8(16):27137-27144. PubMed ID: 28404927
[TBL] [Abstract][Full Text] [Related]
10. A Biomarker Panel Increases the Diagnostic Performance for Epithelial Ovarian Cancer Type I and II in Young Women.
Leandersson P; Kalapotharakos G; Henic E; Borgfeldt H; Petzold M; Høyer-Hansen G; Borgfeldt C
Anticancer Res; 2016 Mar; 36(3):957-65. PubMed ID: 26976984
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic significance assessment of the circulating cell-free DNA in ovarian cancer: An updated meta-analysis.
Li B; Pu K; Ge L; Wu X
Gene; 2019 Sep; 714():143993. PubMed ID: 31330238
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-21 was a promising biomarker for lung carcinoma diagnosis: An update meta-analysis.
Wang H; Xu J; Ding L
Thorac Cancer; 2022 Feb; 13(3):316-321. PubMed ID: 34837469
[TBL] [Abstract][Full Text] [Related]
13. [Meta-analysis on the diagnostic value of laser Doppler imaging for burn depth].
Huang Y; Qiu L; Mei AL; Li JX
Zhonghua Shao Shang Za Zhi; 2017 May; 33(5):301-308. PubMed ID: 28651422
[No Abstract] [Full Text] [Related]
14. [The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion].
Wei F; Wei Y; Li LF; Li GL; Wang GJ
Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):524-527. PubMed ID: 28728299
[No Abstract] [Full Text] [Related]
15. The prognostic value of B7-H4 in pancreatic cancer: Systematic review and meta-analysis.
Chen X; Tao L; Yuan C; Xiu D
Medicine (Baltimore); 2018 Mar; 97(12):e0088. PubMed ID: 29561406
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of serum human epididymis protein 4 and cancer antigen 125 in the patients with ovarian carcinoma: A protocol for systematic review and meta-analysis.
Dai HY; Hu F; Ding Y
Medicine (Baltimore); 2021 May; 100(21):e25981. PubMed ID: 34032711
[TBL] [Abstract][Full Text] [Related]
17. Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis: a systematic review.
Ferraro S; Braga F; Lanzoni M; Boracchi P; Biganzoli EM; Panteghini M
J Clin Pathol; 2013 Apr; 66(4):273-81. PubMed ID: 23426716
[TBL] [Abstract][Full Text] [Related]
18. In Silico screening of circulating tumor DNA, circulating microRNAs, and long non-coding RNAs as diagnostic molecular biomarkers in ovarian cancer: A comprehensive meta-analysis.
Zhang L; Hu C; Huang Z; Li Z; Zhang Q; He Y
PLoS One; 2021; 16(4):e0250717. PubMed ID: 33901236
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic measures comparison for ovarian malignancy risk in Epithelial ovarian cancer patients: a meta-analysis.
Suri A; Perumal V; Ammalli P; Suryan V; Bansal SK
Sci Rep; 2021 Aug; 11(1):17308. PubMed ID: 34453074
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of total plasma lysophosphatidic acid in ovarian cancer: a meta-analysis.
Lu Z; Chen Y; Hu Z; Hu C
Int J Gynecol Cancer; 2015 Jan; 25(1):18-23. PubMed ID: 25398018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
